Bioinformatics and mutations leading to exon skipping.

Our knowledge about human genes and the consequences of mutations leading to human genetic diseases has drastically improved over the last few years. It has been recognized that many mutations are indeed pathogenic because they impact the mRNA rather than the protein itself. With our better understanding of the very complex mechanism of splicing, various bioinformatics tools have been developed. They are now frequently used not only to search for sequence motifs corresponding to splicing signals (splice sites, branch points, ESE, and ESS) but also to predict the impact of mutations on these signals. We now need to address the impact of mutations that affect the splicing process, as their consequences could vary from the activation of cryptic signals to the skipping of one or multiple exons. Despite the major developments of the bioinformatics field coupled to experimental data generated on splicing, it is today still not possible to efficiently predict the consequences of mutations impacting splicing signals, especially to predict if they will lead to exon skipping or to cryptic splice site activation.

[1]  Sigve Nakken,et al.  Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: Comparison of wet-lab and bioinformatics analyses. , 2009, Molecular genetics and metabolism.

[2]  Christopher B. Burge,et al.  RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons , 2004, Nucleic Acids Res..

[3]  C Béroud,et al.  UMD (Universal Mutation Database): A generic software to build and analyze locus‐specific databases , 2000, Human mutation.

[4]  G. Holder,et al.  ADVIRC is caused by distinct mutations in BEST1 that alter pre-mRNA splicing , 2008, Journal of Medical Genetics.

[5]  A. Soutar,et al.  Genetic diagnosis of familial hypercholesterolaemia: the importance of functional analysis of potential splice-site mutations , 2008, Journal of Medical Genetics.

[6]  A. Monaco,et al.  An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. , 1988, Genomics.

[7]  L. Shkreta,et al.  hnRNP proteins and splicing control. , 2007, Advances in experimental medicine and biology.

[8]  M. Sinnreich,et al.  Lariat branch point mutation in the dysferlin gene with mild limb-girdle muscular dystrophy , 2006, Neurology.

[9]  Richard J. Thompson,et al.  Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre‐messenger RNA splicing , 2009, Hepatology.

[10]  M. Vihinen,et al.  Recommendations for locus‐specific databases and their curation , 2008 .

[11]  Michael Miller,et al.  Multiple splice defects in ABCA1 cause low HDL-C in a family with Hypoalphalipoproteinemia and premature coronary disease , 2009, BMC Medical Genetics.

[12]  G. Butler-Browne,et al.  Efficient bypass of mutations in dysferlin deficient patient cells by antisense‐induced exon skipping , 2010, Human mutation.

[13]  Christophe Béroud,et al.  Genotype–phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD–DMD database: a model of nationwide knowledgebase , 2009, Human mutation.

[14]  Melissa S Jurica,et al.  Pre-mRNA splicing: awash in a sea of proteins. , 2003, Molecular cell.

[15]  S. Perlman,et al.  Aberrant Splicing of the Senataxin Gene in a Patient with Ataxia with Oculomotor Apraxia Type 2 , 2009, The Cerebellum.

[16]  B. Crompton,et al.  Reversible severe combined immunodeficiency phenotype secondary to a mutation of the proton-coupled folate transporter. , 2009, Clinical immunology.

[17]  I. Fokkema,et al.  LOVD: Easy creation of a locus‐specific sequence variation database using an “LSDB‐in‐a‐box” approach , 2005, Human mutation.

[18]  Dominique Stoppa-Lyonnet,et al.  Evaluation of in silico splice tools for decision‐making in molecular diagnosis , 2008, Human mutation.

[19]  Robert Kincaid,et al.  Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Mullikin,et al.  Genomic features defining exonic variants that modulate splicing , 2010, Genome Biology.

[21]  Thierry Soussi,et al.  UMD (Universal Mutation Database): 2005 update , 2005, Human mutation.

[22]  M. Matsuo,et al.  Autosomal dominant pseudohypoaldosteronism type 1 with a novel splice site mutation in MR gene , 2009, BMC nephrology.

[23]  J. Královičová,et al.  Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition , 2007, Nucleic acids research.

[24]  J. Hampe,et al.  Single base‐pair substitutions in exon–intron junctions of human genes: nature, distribution, and consequences for mRNA splicing , 2007, Human mutation.

[25]  A. Zagari,et al.  Functional and structural characterization of novel mutations and genotype–phenotype correlation in 51 phenylalanine hydroxylase deficient families from Southern Italy , 2009, The FEBS journal.

[26]  Ting Liang,et al.  Two novel FBN1 mutations associated with ectopia lentis and marfanoid habitus in two Chinese families , 2009, Molecular vision.

[27]  C. Burge,et al.  A computational analysis of sequence features involved in recognition of short introns , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Batlle,et al.  Novel Null-Allele Mutations and Genotype-Phenotype Correlation in Argentinean Patients with Erythropoietic Protoporphyria , 2009, Molecular medicine.

[29]  H. Kayserili,et al.  Identification of loss-of-function mutations of SLC35D1 in patients with Schneckenbecken dysplasia, but not with other severe spondylodysplastic dysplasias group diseases , 2009, Journal of Medical Genetics.

[30]  C. Béroud,et al.  Introducing the online version of the gene table for neuromuscular disease (nuclear genes only) , 2005, Neuromuscular Disorders.

[31]  T. Jap,et al.  Six new mutations of the thyroglobulin gene discovered in taiwanese children presenting with thyroid dyshormonogenesis. , 2009, The Journal of clinical endocrinology and metabolism.

[32]  Jinhua Wang,et al.  ESEfinder: a web resource to identify exonic splicing enhancers , 2003, Nucleic Acids Res..

[33]  Schraga Schwartz,et al.  SROOGLE: webserver for integrative, user-friendly visualization of splicing signals , 2009, Nucleic Acids Res..

[34]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[35]  M. Dubé,et al.  Mutation in pyrroline-5-carboxylate reductase 1 gene in families with cutis laxa type 2. , 2009, American journal of human genetics.

[36]  M. Saito,et al.  A novel de novo splice‐site mutation in the COL7A1 gene in dominant dystrophic epidermolysis bullosa (DDEB): specific exon skipping could be a prognostic factor for DDEB pruriginosa , 2009, Clinical and experimental dermatology.

[37]  Kinji Ohno,et al.  Human branch point consensus sequence is yUnAy , 2008, Nucleic acids research.

[38]  W. Annaert,et al.  Cerebrocostomandibular-like syndrome and a mutation in the conserved oligomeric Golgi complex, subunit 1. , 2008, Human molecular genetics.

[39]  Mathew W. Wright,et al.  Guidelines for human gene nomenclature. , 2002, Genomics.

[40]  D. Cooper,et al.  Identification and molecular characterization of six novel mutations in the UDP‐N‐acetylglucosamine‐1‐phosphotransferase gamma subunit (GNPTG) gene in patients with mucolipidosis III gamma , 2009, Human mutation.

[41]  L. Chasin,et al.  Searching for splicing motifs. , 2007, Advances in experimental medicine and biology.

[42]  P. Jordan,et al.  A missense mutation in the APC tumor suppressor gene disrupts an ASF/SF2 splicing enhancer motif and causes pathogenic skipping of exon 14. , 2009, Mutation research.

[43]  Alan F. Scott,et al.  McKusick's Online Mendelian Inheritance in Man (OMIM®) , 2008, Nucleic Acids Res..

[44]  D. Barisani,et al.  Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2 , 2009, Haematologica.

[45]  M. Bashyam.  Nonsense-mediated decay: linking a basic cellular process to human disease , 2009, Expert review of molecular diagnostics.

[46]  J. Cruces,et al.  A double homozygous mutation in the POMT1 gene involving exon skipping gives rise to Walker‐Warburg syndrome in two Spanish Gypsy families , 2009, Clinical genetics.

[47]  L. Chasin,et al.  Computational definition of sequence motifs governing constitutive exon splicing. , 2004, Genes & development.

[48]  R. Weiss,et al.  Autosomal recessive inheritance of classic Bethlem myopathy , 2009, Neuromuscular Disorders.

[49]  D. Marsh,et al.  The effect of disease-associated HRPT2 mutations on splicing. , 2009, The Journal of endocrinology.

[50]  P. Stenson,et al.  The Human Gene Mutation Database (HGMD) and Its Exploitation in the Study of Mutational Mechanisms , 2005, Current protocols in bioinformatics.

[51]  E. Bertini,et al.  Identification and characterization of novel collagen VI non‐canonical splicing mutations causing ullrich congenital muscular dystrophy , 2009, Human mutation.

[52]  W. Ahmad,et al.  A novel splice‐site mutation in the CDH3 gene in hypotrichosis with juvenile macular dystrophy , 2009, Clinical and experimental dermatology.

[53]  W. Gahl,et al.  Hermansky-Pudlak syndrome type 1 in patients of Indian descent. , 2009, Molecular genetics and metabolism.

[54]  N. Bresolin,et al.  Silencer elements as possible inhibitors of pseudoexon splicing. , 2004, Nucleic acids research.

[55]  Gene W. Yeo,et al.  Systematic Identification and Analysis of Exonic Splicing Silencers , 2004, Cell.

[56]  I. Cortella,et al.  Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia. , 2009, Molecular genetics and metabolism.

[57]  J. D. den Dunnen,et al.  Array‐MLPA: comprehensive detection of deletions and duplications and its application to DMD patients , 2008, Human mutation.

[58]  Y. Takeshima,et al.  In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G→A mutations in introns of the dystrophin gene , 2008, Journal of Medical Genetics.

[59]  R. Fahsold,et al.  Independent NF1 and PTPN11 mutations in a family with neurofibromatosis‐Noonan syndrome , 2009, American journal of medical genetics. Part A.

[60]  S. Karlin,et al.  Finding the genes in genomic DNA. , 1998, Current opinion in structural biology.

[61]  Christopher B. Burge,et al.  Maximum Entropy Modeling of Short Sequence Motifs with Applications to RNA Splicing Signals , 2004, J. Comput. Biol..

[62]  G. Ast,et al.  Comparative analysis identifies exonic splicing regulatory sequences--The complex definition of enhancers and silencers. , 2006, Molecular cell.

[63]  G. Matthijs,et al.  Functional analysis of three splicing mutations identified in the PMM2 gene: Toward a new therapy for congenital disorder of glycosylation type Ia , 2009, Human mutation.

[64]  Christophe Béroud,et al.  Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy , 2007, Human mutation.

[65]  Peter J. Shepard,et al.  The SR protein family , 2009, Genome Biology.

[66]  Christina S Leslie,et al.  Computational searches for splicing signals. , 2005, Methods.

[67]  Cathy H. Wu,et al.  The Universal Protein Resource (UniProt) , 2004, Nucleic Acids Res..

[68]  Y. Takeshima,et al.  In vivo and in vitro splicing assay of SLC12A1 in an antenatal salt-losing tubulopathy patient with an intronic mutation , 2009, Human Genetics.

[69]  S. Antonarakis,et al.  Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2000 .

[70]  H. Le Hir,et al.  The spliceosome deposits multiple proteins 20–24 nucleotides upstream of mRNA exon–exon junctions , 2000, The EMBO journal.

[71]  Michael Q. Zhang,et al.  RNA landscape of evolution for optimal exon and intron discrimination , 2008, Proceedings of the National Academy of Sciences.

[72]  C. Davie,et al.  Characterization of a novel TYMP splice site mutation associated with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) , 2009, Neuromuscular Disorders.

[73]  Mireille Régnier,et al.  Using Profiles Based on Nucleotide Hydrophobicity to Define Essential Regions for Splicing , 2008, International journal of biological sciences.

[74]  P. Herrlich,et al.  Coupling of signal transduction to alternative pre‐mRNA splicing by a composite splice regulator , 1998, The EMBO journal.

[75]  Bing-Li Liu,et al.  A splice site mutation combined with a novel missense mutation of LHCGR cause male pseudohermaphroditism , 2009, Human mutation.

[76]  C. Zweier,et al.  New Mutations of EXT1 and EXT2 Genes in German Patients with Multiple Osteochondromas , 2009, Annals of human genetics.

[77]  C. Burge,et al.  Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. , 2008, RNA.

[78]  Johan T den Dunnen,et al.  Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker , 2008, Human mutation.

[79]  Christopher B. Burge,et al.  Classification of Introns: U2-Type or U12-Type , 1997, Cell.

[80]  G. Dekomien,et al.  Detecting copy number variations in autosomal recessive limb-girdle muscular dystrophies using a multiplex ligation-dependent probe amplification (MLPA) assay. , 2009, Molecular and cellular probes.

[81]  S. Perrotta,et al.  β-spectrinBari: a truncated β-chain responsible for dominant hereditary spherocytosis , 2009, Haematologica.

[82]  N L Harris,et al.  Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. , 1990, Methods in enzymology.

[83]  Teresa Casals,et al.  New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12. , 2003, Human molecular genetics.